Enovix (ENVX) Return on Sales (2022 - 2026)

Enovix has reported Return on Sales for 5 years, with the latest figure at 0.05% in Q2 2026.

• For the quarter ending Q2 2026, Return on Sales changed 0.0% year-over-year to 0.05%; the trailing twelve-month figure through Apr 2026 stood at 0.05% (up 4.0% YoY), and the FY2025 full-year result was 0.05%, up 5.0% from the prior year.
• Return on Sales for Q2 2026 stood at 0.05%, down from 0.03% in the prior quarter.
• The five-year high for Return on Sales was 0.03% in Q4 2025, with the low at 39.92% in Q4 2022.
• Historically, Return on Sales has averaged 5.76% across 5 years, with a median of 0.07% in 2025.
• The largest YoY upside for Return on Sales was 3911 bps in 2023 against a maximum downside of 1526 bps in 2023.
• Enovix's Return on Sales stood at 39.92% in 2022, then surged by 100 bps to 0.08% in 2023, then jumped by 53 bps to 0.04% in 2024, then rose by 19 bps to 0.03% in 2025, then plunged by 62 bps to 0.05% in 2026.
• The last three Return on Sales figures came in at 0.05% (Q2 2026), 0.03% (Q4 2025), and 0.07% (Q3 2025), per Business Quant data.